Xencor, Inc. (XNCR)
NASDAQ · Manufacturing · Pharmaceutical preparations
$23.80−$0.0800 (−0.34%) on the dayAs of the close; data may be delayed.
XNCR price, last 12 months
Key stats
- Previous close
- $23.88
- Open
- $23.90
- Day range
- $23.31 – $24.29
- 52-week range
- $10.24 – $30.61
- Volume
- 614.1K
- Avg volume (20 days)
- 1.4M
- Market cap
- $1.8B
Performance
1W−3.7%
1M−16.3%
3M+58.1%
6M+93.3%
YTD+55.5%
1Y+127.3%
vs S&P 500, 1Y+110.5 pts
Technicals and fundamentals
About Xencor, Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.8B